Dr. Susie Cohn, MD

NPI: 1205161130
Total Payments
$13,313
2024 Payments
$2,723
Companies
38
Transactions
583
Medicare Patients
3,611
Medicare Billing
$472,766

Payment Breakdown by Category

Food & Beverage$13,170 (98.9%)
Education$142.55 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,170 579 98.9%
Education $142.55 4 1.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $4,462 179 $0 (2024)
Janssen Biotech, Inc. $2,712 114 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,254 67 $0 (2024)
Celgene Corporation $808.65 45 $0 (2024)
Lilly USA, LLC $545.96 14 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $469.27 23 $0 (2024)
PFIZER INC. $460.27 27 $0 (2024)
Gilead Sciences, Inc. $335.73 19 $0 (2023)
GENZYME CORPORATION $263.72 6 $0 (2024)
QOL Medical, LLC $247.10 11 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,723 100 ABBVIE INC. ($746.87)
2023 $2,998 105 AbbVie Inc. ($984.24)
2022 $2,122 93 ABBVIE INC. ($893.41)
2021 $1,633 82 AbbVie Inc. ($569.61)
2020 $814.38 34 AbbVie Inc. ($454.93)
2019 $660.58 47 Janssen Biotech, Inc. ($134.60)
2018 $1,288 66 AbbVie, Inc. ($335.84)
2017 $1,074 56 AbbVie, Inc. ($404.83)

All Payment Transactions

583 individual payment records from CMS Open Payments — Page 1 of 24

Date Company Product Nature Form Amount Type
12/20/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $28.15 General
Category: IMMUNOLOGY
12/19/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $21.72 General
Category: INTERNAL MEDICINE
12/17/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $32.20 General
Category: IMMUNOLOGY
12/13/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $22.17 General
Category: INTERNAL MEDICINE
12/11/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $31.42 General
Category: Immunology
12/10/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $29.24 General
Category: IMMUNOLOGY
12/05/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.91 General
Category: Gastroenterology
11/21/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $143.21 General
Category: Immunology
11/19/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $23.42 General
Category: Immunology
11/14/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $13.81 General
Category: INTERNAL MEDICINE
11/12/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $29.87 General
Category: Immunology
11/07/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $19.39 General
Category: GASTROENTEROLOGY
11/05/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $15.92 General
Category: ONCOLOGY
11/01/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $26.66 General
Category: Immunology
10/30/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $25.58 General
Category: IMMUNOLOGY
10/29/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $21.27 General
Category: THERAPY FOR CSID
10/28/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug), PLENVU Food and Beverage In-kind items and services $14.69 General
Category: Gastroenterology
10/25/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $28.65 General
Category: IMMUNOLOGY
10/24/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $28.71 General
Category: Immunology
10/22/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $32.63 General
Category: Immunology
10/15/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $33.29 General
Category: Immunology
10/11/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $20.71 General
Category: Rare Disease
10/08/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $18.06 General
Category: GASTROENTEROLOGY
10/08/2024 VIVUS LLC PANCREAZE (Drug) Food and Beverage In-kind items and services $15.11 General
Category: GASTROENTEROLOGY
10/02/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $30.91 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 847 902 $528,324 $108,077
2022 16 1,041 1,103 $631,564 $132,252
2021 10 889 951 $571,110 $123,708
2020 14 834 937 $448,049 $108,729
Total Patients
3,611
Total Services
3,893
Medicare Billing
$472,766
Procedure Codes
54

All Medicare Procedures & Services

54 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 177 178 $216,920 $40,999 18.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 199 222 $47,497 $15,656 33.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 130 133 $108,254 $12,636 11.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 56 56 $21,683 $8,609 39.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 90 90 $29,456 $7,944 27.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 46 61 $12,377 $6,434 52.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 33 33 $36,244 $3,444 9.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 18 18 $16,650 $3,296 19.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 22 29 $8,327 $3,055 36.7%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 23 23 $20,595 $2,807 13.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 13 19 $2,705 $1,333 49.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $2,624 $906.33 34.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 16 16 $2,266 $904.00 39.9%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2023 12 12 $2,726 $51.78 1.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 212 213 $262,303 $46,137 17.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 262 298 $63,757 $23,131 36.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 170 170 $55,639 $15,247 27.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 125 126 $102,887 $11,164 10.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 37 37 $14,326 $6,471 45.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 37 42 $12,059 $5,635 46.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 19 19 $17,952 $3,804 21.2%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 25 25 $22,512 $3,704 16.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 32 40 $8,116 $3,612 44.5%
43270 Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 18 19 $13,701 $3,496 25.5%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 15 15 $13,875 $2,983 21.5%

About Dr. Susie Cohn, MD

Dr. Susie Cohn, MD is a Gastroenterology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205161130.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susie Cohn, MD has received a total of $13,313 in payments from pharmaceutical and medical device companies, with $2,723 received in 2024. These payments were reported across 583 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($13,170).

As a Medicare-enrolled provider, Cohn has provided services to 3,611 Medicare beneficiaries, totaling 3,893 services with total Medicare billing of $472,766. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Oakland, CA
  • Active Since 10/09/2009
  • Last Updated 11/20/2023
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1205161130

Products in Payments

  • STELARA (Biological) $2,229
  • RINVOQ (Biological) $1,166
  • ENTYVIO (Biological) $981.61
  • HUMIRA (Biological) $936.79
  • ZEPOSIA (Drug) $933.58
  • SKYRIZI (Biological) $814.33
  • OMVOH (Drug) $522.16
  • Mavyret (Drug) $391.92
  • TREMFYA (Drug) $372.14
  • XELJANZ (Drug) $334.68
  • MAVYRET (Drug) $301.23
  • DUPIXENT (Biological) $289.25
  • LINZESS (Drug) $268.14
  • Entyvio (Biological) $261.84
  • TRULANCE (Drug) $226.57
  • REMICADE (Biological) $221.73
  • OCALIVA (Drug) $204.81
  • Humira (Biological) $187.01
  • XIFAXAN (Drug) $176.94
  • CREON (Drug) $174.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Oakland